StoneX Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $269K | Sell |
2,129
-15
| -0.7% | -$1.9K | 0.01% | 692 |
|
|
2025
Q1 | $274K | Buy |
2,144
+245
| +13% | +$31.3K | 0.02% | 674 |
|
|
2024
Q4 | $251K | Sell |
1,899
-248
| -12% | -$32.8K | 0.01% | 677 |
|
|
2024
Q3 | $313K | Buy |
2,147
+91
| +4% | +$13.2K | 0.14% | 203 |
|
|
2024
Q2 | $282K | Sell |
2,056
-14
| -0.7% | -$1.92K | 0.13% | 222 |
|
|
2024
Q1 | $284K | Sell |
2,070
-32
| -2% | -$4.39K | 0.15% | 198 |
|
|
2023
Q4 | $286K | Sell |
2,102
-154
| -7% | -$20.9K | 0.15% | 193 |
|
|
2023
Q3 | $276K | Sell |
2,256
-424
| -16% | -$51.9K | 0.15% | 200 |
|
|
2023
Q2 | $340K | Sell |
2,680
-12
| -0.4% | -$1.52K | 0.19% | 154 |
|
|
2023
Q1 | $348K | Sell |
2,692
-134
| -5% | -$17.3K | 0.21% | 147 |
|
|
2022
Q4 | $371K | Sell |
2,826
-110
| -4% | -$14.4K | 0.05% | 267 |
|
|
2022
Q3 | $343K | Sell |
2,936
-1,613
| -35% | -$189K | 0.06% | 200 |
|
|
2022
Q2 | $535K | Sell |
4,549
-1,801
| -28% | -$212K | 0.09% | 164 |
|
|
2022
Q1 | $827K | Buy |
6,350
+3,867
| +156% | +$504K | 0.08% | 219 |
|
|
2021
Q4 | $379K | Buy |
2,483
+248
| +11% | +$37.9K | 0.04% | 350 |
|
|
2021
Q3 | $361K | Buy |
2,235
+444
| +25% | +$71.7K | 0.05% | 315 |
|
|
2021
Q2 | $293K | Buy |
1,791
+463
| +35% | +$75.7K | 0.04% | 362 |
|
|
2021
Q1 | $200K | Buy |
+1,328
| New | +$200K | 0.04% | 399 |
|
|
2019
Q2 | – | Sell |
-1,798
| Closed | -$201K | – | 247 |
|
|
2019
Q1 | $201K | Buy |
+1,798
| New | +$201K | 0.15% | 218 |
|
|
2018
Q4 | – | Sell |
-2,002
| Closed | -$244K | – | 219 |
|
|
2018
Q3 | $244K | Buy |
+2,002
| New | +$244K | 0.18% | 196 |
|